Research Roundup

Debbie Rigby rounds up the latest in research news A Practical Approach to Low-Dose Aspirin for Primary Prevention New clinical trials suggest a reduced benefit of aspirin for preventing first CVD events, but confirm sizable bleeding harms. After a CVD-defining event, use of aspirin, another antiplatelet agent, or both remains mandatory, although aspirin is underused